VIP
VIP (vasoactive intestinal peptide) is a natural signaling molecule made of 28 amino acids that the body produces in the gut, brain, lungs and other tissues. It is discussed for mold illness (CIRS) and inflammation, but human outcome evidence is thin for most marketed uses.
At a glance
- Peptide
- intranasal
- Not yet audited here; the reference library calls it observational
- 100 mcg per Peptide Dosing Protocols. All 3 sources
- 10 mg in 3 mL
How much to draw
Full calculator →Opened on 100 mcg, the figure Peptide Dosing Protocols reports for VIP, and a 10 mg vial in 3 mL. A reported amount, not a recommendation. Change any number to match the vial in your hand. How to reconstitute a vial.
What sources report
These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for VIP or for anything else, and nothing below has been checked against the study it came from.
| Amount | Frequency | Route | Reported by |
|---|---|---|---|
| 50 mcg per spray, 4-8 sprays daily (CIRS/nasal); 50-150 pmol/kg/min (IV infusion) | not stated | intranasal or oral | Peptide Protocol Wiki |
| Standard: 100 mcg · Low: 50 mcg · High: 200 mcg | 1-2x dailyOngoing · 12 week cycles. | SubQ | Peptide Dosing ProtocolsWhat it saysHideHalf-life: very short. The standard dosing for VIP is 100 mcg taken 1-2 times daily. |
| 50 mcg per spray intranasally, up to 4 times daily (titrate per CIRS protocol; typically after correcting other abnormalities) | up to 4 times dailyPer provider direction · Per provider direction | intranasal | Commonly published practitioner dosing range - provider confirmation required. |
- not stated
- intranasal or oral
- Peptide Protocol Wiki
- 1-2x dailyOngoing · 12 week cycles.
- SubQ
- Peptide Dosing Protocols
What it saysHide
Half-life: very short. The standard dosing for VIP is 100 mcg taken 1-2 times daily.
- up to 4 times dailyPer provider direction · Per provider direction
- intranasal
- Commonly published practitioner dosing range - provider confirmation required.
- Sterile 0.9% saline
- A 10 mg subcutaneous vial with 3 mL bacteriostatic water gives about 3.33 mg/mL.
- Compounded intranasal spray (e.g. 50 mcg/actuation) · Compounded intranasal spray - no reconstitution required
We have not published an audit on VIP. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
VIP appears to relax smooth muscle, widen blood vessels and help calm inflammation. Researchers link this to two receptors, VPAC1 and VPAC2, which raise cyclic AMP (cAMP) inside cells, and to its activity in the suprachiasmatic nucleus, the brain's master clock. The basic biology is well described, but most claimed uses have not been proven in well-controlled human trials.
Neuro-immune and inflammatory signaling.
Reported side effects
Seen in studies: in trials of IV aviptadil, diarrhea and low blood pressure were the known side effects, and they were described as manageable in a hospital setting.
Reported by users: flushing, mild headache, dizziness or lightheadedness, and loose stools. The dizziness is put down to wider blood vessels and lower blood pressure.
Not ruled out: effects on the pancreas. A rise in lipase, a blood marker for the pancreas, or new belly pain is the documented reason to stop VIP, which is why protocols built around it check lipase before and during use.
Who should avoid it
People with a history of pancreatitis or raised lipase: VIP can affect the pancreas.
Pregnant or breastfeeding people: safety has not been established in these groups.
People with active cancer: VIP receptors are overexpressed on some tumors, which is a theoretical concern.
People with low blood pressure: VIP can lower blood pressure further.
What gets monitored
Lipase is checked before and during use, with rechecks after the first dose, about two weeks in, and after any increase. (reported by Peptide Dosing Protocols)
Common questions
What is VIP peptide?
VIP stands for vasoactive intestinal peptide, a natural neuropeptide made of 28 amino acids. The body makes it in the gut, brain, lungs and other tissues. It was first isolated from pig intestine in 1970, which is where the name comes from.
What is VIP peptide used for?
It is researched for inflammation, lung function, gut signaling and circadian rhythm. Human outcome evidence is thin for most marketed uses. The mold illness (CIRS) use rests on small open-label studies of around 15 to 20 patients from one research group, with no placebo-controlled trial.
How is VIP peptide dosed?
Reported amounts and schedules for VIP differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.
Is VIP nasal spray different from VIP injection?
Yes. The nasal spray is pre-compounded and is not interchangeable with the injection. The source lists four separate product contexts (compounded nasal spray, subcutaneous research vials, aviptadil and Invicorp) and says they are not the same thing.
What are the side effects of VIP peptide?
Reported effects include flushing, headache, dizziness, low blood pressure and loose stools. The main safety signal in the source is the pancreas: rising lipase or new belly pain is the documented reason to stop.
Does VIP peptide help with erectile dysfunction?
A penile-injection combination of aviptadil (VIP) and phentolamine, sold as Invicorp, is licensed in some European countries as a second- or third-line option. Retrospective case series report that it can work and may hurt less than alprostadil. It is not FDA-approved in the US.
Did VIP (aviptadil) work for COVID-19?
No. The NIH trial, ACTIV-3b / TESICO, found that IV aviptadil did not significantly improve outcomes through day 90 compared with placebo. The FDA declined an emergency use authorization.
Is VIP peptide FDA-approved?
Not as a standalone drug; the reference library describes it as under evaluation. The FDA declined an emergency use authorization for IV aviptadil, and the Invicorp combination is not FDA-approved in the US.
Sources
- 01Said SI, Mutt V Polypeptide with broad biological activity: isolation from small intestine. Science (1970)
- 02ACTIV-3b/TESICO Study Group (Brown SM, et al.) Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial. The Lancet Respiratory Medicine (2023)
- 03NRx Pharmaceuticals / NIAID Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (NCT04311697). ClinicalTrials.gov (2022)
- 04Shoemaker RC, House D, Ryan JC Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health (2013)
- 05Ryan JC, Shoemaker RC RNA-Seq on patients with CIRS treated with VIP shows a shift in metabolic state and innate immune functions that coincide with healing. Medical Research Archives (2016)
- 06Dinsmore WW, Wyllie MG Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction. BJU International (2008)
- 07Al-Mitwalli A, Holden F, Lee WG, et al. Intracavernosal injection of aviptadil and phentolamine for refractory erectile dysfunction. The Journal of Sexual Medicine (2025)
- 08U.S. Food & Drug Administration Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act. FDA (2026)
- 09Asebey EJ, et al. (Frier Levitt) FDA Peptide Regulation May Shift: compounding categories for VIP, GHK-Cu, and other peptides. Frier Levitt (legal analysis) (2026)
- 10Managed Healthcare Executive FDA Declines EUA Request for Zyesami (aviptadil) for COVID-19. Managed Healthcare Executive (2022)
- 11Temerozo JR, et al. Anticipated pharmacological role of aviptadil (synthetic VIP): VPAC receptor mechanism and lung biology. PMC (review) (2021)
The reference sections on this page come from a compound library we import, not from our own review of the studies. Our own evidence grade appears only where an audit is linked. Research use only; nothing here is medical advice or a protocol.
Selank is a lab-made peptide of seven amino acids, based on tuftsin, a small immune-related molecule the body makes on its own. It has been studied mainly in Russian human trials of anxiety, and in animal work on nerve-cell growth signals.
Semax is a lab-made peptide of seven amino acids, built from a piece of the stress hormone ACTH with a short tail added to slow its breakdown. It is studied mainly as a nasal spray in rats and in Russian clinical work on stroke recovery, stress and cognition.